We are live on ! Find out more
Ensign Peak Advisors

Ensign Peak Advisors Portfolio holdings

AUM $53.7B
1-Year Est. Return 29.47%
This Fund
S&P 500
This Quarter Est. Return
+11.03%
1 Year Est. Return
+29.47%
3 Year Est. Return
+102.45%
5 Year Est. Return
+139.11%
10 Year Est. Return
AUM
$60.9B
AUM Growth
+$2.53B
Cap. Flow
-$2.05B
Cap. Flow %
-3.37%
Top 10 Hldgs %
34.77%
Holding
1,731
New
34
Increased
253
Reduced
1,344
Closed
34

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$163M
2
FOUR icon
Shift4
FOUR
+$127M
3
TMO icon
Thermo Fisher Scientific
TMO
+$126M
4
ELF icon
e.l.f. Beauty
ELF
+$94.4M
5
KKR icon
KKR & Co
KKR
+$84.6M

Sector Composition

Rank Sector Weight
1 Technology 33.11%
2 Financials 12.96%
3 Healthcare 11.29%
4 Communication Services 9.96%
5 Consumer Discretionary 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
GO icon
1401
Grocery Outlet
GO
$902M
$485K ﹤0.01%
30,215
-28,950
-49% -$462K
CDTX
1402
DELISTED
Cidara Therapeutics
CDTX
$479K ﹤0.01%
5,000
OGN icon
1403
Organon & Co
OGN
$3.55B
$479K ﹤0.01%
44,809
-8,950
-17% -$87.8K
PHR icon
1404
Phreesia
PHR
$671M
$477K ﹤0.01%
20,291
-2,200
-10% -$59.8K
COMP icon
1405
Compass
COMP
$8.88B
$475K ﹤0.01%
+59,150
New +$479K
ARCB icon
1406
ArcBest
ARCB
$3.33B
$474K ﹤0.01%
6,777
ONON icon
1407
On Holding
ONON
$12.6B
$473K ﹤0.01%
+11,160
New +$531K
PCRX icon
1408
Pacira BioSciences
PCRX
$1.05B
$472K ﹤0.01%
18,320
-2,700
-13% -$66.3K
STRA icon
1409
Strategic Education
STRA
$1.84B
$472K ﹤0.01%
5,488
-4,700
-46% -$378K
RAL
1410
Ralliant Corp
RAL
$7.58B
$469K ﹤0.01%
10,733
-185,757
-95% -$8.26M
VKTX icon
1411
Viking Therapeutics
VKTX
$3.93B
$467K ﹤0.01%
17,789
-18,900
-52% -$564K
MD icon
1412
Pediatrix Medical
MD
$2.21B
$466K ﹤0.01%
27,804
-21,650
-44% -$324K
SR icon
1413
Spire
SR
$4.88B
$465K ﹤0.01%
5,709
-11,100
-66% -$844K
CWT icon
1414
California Water Service
CWT
$3.14B
$464K ﹤0.01%
10,114
-13,900
-58% -$640K
BWIN
1415
Baldwin Insurance Group
BWIN
$2.79B
$464K ﹤0.01%
16,448
-10,750
-40% -$373K
ADEA icon
1416
Adeia
ADEA
$2.77B
$463K ﹤0.01%
27,545
-23,250
-46% -$345K
DRVN icon
1417
Driven Brands
DRVN
$2.47B
$462K ﹤0.01%
28,706
-18,750
-40% -$327K
HP icon
1418
Helmerich & Payne
HP
$3.31B
$461K ﹤0.01%
20,862
-17,750
-46% -$327K
VYX icon
1419
NCR Voyix
VYX
$1.19B
$460K ﹤0.01%
36,683
-16,100
-31% -$212K
NSA
1420
DELISTED
National Storage Affiliates Trust
NSA
$460K ﹤0.01%
15,230
-16,850
-53% -$526K
NSIT icon
1421
Insight Enterprises
NSIT
$3.77B
$459K ﹤0.01%
4,043
-2,250
-36% -$293K
GRAL
1422
GRAIL Inc
GRAL
$2.76B
$457K ﹤0.01%
7,727
-5,150
-40% -$197K
HTHT icon
1423
Huazhu Hotels Group
HTHT
$13.2B
$454K ﹤0.01%
11,600
-6,500
-36% -$227K
HAE icon
1424
Haemonetics
HAE
$3.75B
$452K ﹤0.01%
9,266
-5,300
-36% -$328K
CERT icon
1425
Certara
CERT
$1.23B
$451K ﹤0.01%
36,877
-6,600
-15% -$72.2K

Similar funds

Ensign Peak Advisors's Q3 2025 Portfolio in Review

As of Q3 2025, Ensign Peak Advisors held 1,731 positions worth $60.9B, up 4.3% from $58.4B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Ensign Peak Advisors withdrew a net $2.05B in Q3 2025, closing 34 positions and reducing 1,344 holdings. Its most notable exit was WNS Holdings, an estimated $34M position sold in full.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 31% a quarter earlier, followed by Financials and Healthcare.

Against the trend, Ensign Peak Advisors opened a new position in Heartflow Inc worth $21.1M.

  • Ensign Peak Advisors's largest Q3 2025 buy was Heartflow Inc: 625,812 shares worth $21.1M.
  • Ensign Peak Advisors added most to Amazon in Q3 2025, an estimated $163M increase.
  • Ensign Peak Advisors's biggest Q3 2025 reduction was Eli Lilly, cutting an estimated $181M.
  • Ensign Peak Advisors fully exited WNS Holdings in Q3 2025, selling an estimated $34M.
  • Ensign Peak Advisors's ten largest holdings make up 35% of its $60.9B portfolio in Q3 2025.
  • Ensign Peak Advisors opened 34 new positions and closed 34 in Q3 2025.
  • Ensign Peak Advisors's portfolio value rose 4.3% quarter-over-quarter to $60.9B.

Based on Ensign Peak Advisors's 13F filing for Q3 2025, filed 13 Nov 2025.